TABLE.
Distribution of Functional Outcome Measurements After Glioma Surgery in Publications From 5 Years (2014-2018)
| Publications on functional outcome in glioma surgery | n = 160 |
|---|---|
| Neurological examination | 92 (58%) |
| Muscle strength | 40 (25%) |
| Language | 31 (19%) |
| Vision | 9 (6%) |
| Unspecified | 48 (30%) |
| NIH Stroke Scale | 3 (2%) |
| Neurological Assessment Neuro-Oncology scale | 1 (1%) |
| Activities of daily living | 40 (25%) |
| Karnofsky Performance Scale | 34 (21%) |
| Eastern Cooperative Oncology Group/WHO scale | 4 (3%) |
| Barthel index | 1 (1%) |
| Modified Rankin Scale | 2 (1%) |
| Seizure outcome | 21 (13%) |
| Engel | 8 (5%) |
| Neurocognitive performance | 12 (8%) |
| Well-being/health-related quality of life | 9 (6%) |
| QLQ-C30/BN20 | 6 (4%) |
| EuroQol-5D | 4 (3%) |
| No functional outcome | 43 (27%) |